English  |  正體中文  |  简体中文  |  2853327  
???header.visitor??? :  45111441    ???header.onlineuser??? :  890
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

???jsp.browse.items-by-date.jump???
???jsp.browse.items-by-date.type???
???jsp.browse.items-by-date.recent??? ???jsp.browse.items-by-date.order2???

Showing items 2290511-2290535 of 2346269  (93851 Page(s) Totally)
<< < 91616 91617 91618 91619 91620 91621 91622 91623 91624 91625 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-09-09T04:21:27Z Sofosbuvir/Velpatasvir for Hepatitis?C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; JIA-HORNG KAO; Chuang W.-L.; Yu M.-L.; TACR investigators
臺大學術典藏 2022-09-09T04:21:27Z Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment Liu C.-H.; Peng C.-Y.; Kao W.-Y.; Yang S.-S.; Shih Y.-L.; Lin C.-L.; Tsai M.-K.; Lee C.-Y.; Chang C.-C.; Wu J.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:28Z Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5 Liu C.-H.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:28Z Metabolic dysfunction-associated fatty liver disease and chronic hepatitis B Huang S.-C.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:29Z Looking Into the Crystal Ball: A Novel Biomarker for Outcomes of Patients With Chronic Hepatitis B Virus Infection Tseng T.-C.; Wu J.-W.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:29Z The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan Lin C.-L.; Tai C.-M.; Huang J.-F.; Liu C.-J.; Chen H.-F.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Wang C.-C.; Weng S.-H.; Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:29Z Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA-binding function Li Y.-T.; Liu C.-J.; JIA-HORNG KAO; Lin L.-F.; Tu H.-C.; Wang C.-C.; Huang P.-H.; Cheng H.-R.; Chen P.-J.; Chen D.-S.; Wu H.-L.
臺大學術典藏 2022-09-09T04:21:30Z Letter: hepatic steatosis and fibrosis in chronic hepatitis B—the chicken-and-egg conundrum Huang S.-C.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:30Z Advancing the global public health agenda for NAFLD: a consensus statement Lazarus J.V.; Mark H.E.; Anstee Q.M.; Arab J.P.; Batterham R.L.; Castera L.; Cortez-Pinto H.; Crespo J.; Cusi K.; Dirac M.A.; Francque S.; George J.; Hagstr?m H.; Huang T.T.-K.; Ismail M.H.; Kautz A.; Sarin S.K.; Loomba R.; Miller V.; Newsome P.N.; Ninburg M.; Ocama P.; Ratziu V.; Rinella M.; Romero D.; Romero-G?mez M.; Schattenberg J.M.; Tsochatzis E.A.; Valenti L.; Wong V.W.-S.; Yilmaz Y.; Younossi Z.M.; Zelber-Sagi S.; ?berg F.; Adams L.; Khatry M.S.A.; Naamani K.A.; Murillo O.A.; Allen A.M.; Alnaser F.; Alqahtani S.A.; Alswat K.; Alvaro D.; Andrade R.J.; Arrese M.; Awuku Y.A.; Ayesha M.; Baatarkhuu O.; Bakieva S.; Basu R.; Bataller R.; Bedri S.; Bosi E.; Bourliere M.; Bruha R.; Bugianesi E.; Burra P.; Buti M.; Byrne C.D.; Calleja J.L.; Carrieri P.; Carter F.; Fernandez M.I.C.; Castillo-Lopez G.; Castro-Narro G.E.; Chan H.L.Y.; Chan W.-K.; Chang Y.; Colombo M.; Coppell K.J.; Corey K.; Craxi A.; Cryer D.; Dassanayake A.; Martins A.A.S.; de Ledinghen V.; DelPrato S.; Demaio A.; Desalegn H.; Dillon J.; Duseja A.; Dorairaj P.; Ekstedt M.; El Kassas M.; Elsanousi O.M.; Esmat G.; Fan J.-G.; Farpour-Lambert N.; Flisiak R.; Fouad Y.; Fuchs M.; Gani R.A.; Gerber L.; Ghazinyan H.; Gheorghe L.; Goh G.B.-B.; Gr?nb?k H.; Gulnara A.; Hamid S.; Hebditch V.; Hickman I.J.; Hocking S.L.; Hunyady B.; Idilman R.; Isakov V.A.; Jamal M.H.; Jepsen P.; Iskandar N.J.; Song M.J.; Sudhamshu K.C.; Kakizaki S.; Kalamitsis G.; Kanwal F.; JIA-HORNG KAO; Kaplan L.; Kawaguchi T.; Khader Y.; Kim S.U.; Kodjoh N.; Koek G.; Koike K.; Komas N.P.; Korenjak M.; Kugelmas M.; Labidi A.; Lange N.F.; Lavine J.E.; Lazo M.; Lee N.; Lesmana C.R.A.; Liu C.-J.; Long M.T.; Lopez-Jaramillo P.; Malekzadeh R.; Mahtab M.A.; Marchesini G.; Marinho R.; V?zquez S.E.M.; Mateva L.; Nlombi C.M.; Melin P.; Mikolasevic I.; Milovanovic T.; Musso C.; Nakajima A.; Nava E.; Nersesov A.V.; Nikolova D.; Norris S.; Novak K.; Oben J.; Ong J.P.; Onyekwere C.; Papatheodoridis G.; Paruk I.; Patel K.; Macedo M.P.; Penha-Gon?alves C.; Figueroa M.P.; Hofmann W.P.; Petta S.; de Oliveira C.P.M.S.; Puri P.; Pan C.Q.; Rac M.; Ralston J.; Ramji A.; Razavi H.; Alvares-da-Silva M.R.; Roberts S.; Roden M.; Rose T.; Rouabhia S.; Rovere-Querini P.; Rowe I.A.; Sadirova S.; Salupere R.; Saparbu T.; Sayegh R.; Sebastiani G.; Seki Y.; Selmo J.; Serme A.K.; Shaw J.E.; Shenoy T.; Sheron N.; Shibolet O.; Silva M.; Skrypnyk I.; Socha P.; Soriano J.; Spearman C.W.; Sridharan K.; Su?rez J.J.; Sheriff D.S.; Sung K.-C.; Swain M.; Tacke F.; Taheri S.; Tan S.-S.; Tapper E.B.; Yki-J?rvinen H.; Thiele M.; Shawa I.T.; Tolmane I.; Torres E.A.; Trauner M.; Treeprasertsuk S.; Turcanu A.; Valantinas J.; Vesterhus M.; Waked I.; Wild S.H.; Willemse J.; Wong R.J.; Xanthakos S.; Young D.Y.; Yu M.-L.; Zheng K.I.; Zeybel M.; Zheng M.-H.; the NAFLD Consensus Consortium
臺大學術典藏 2022-09-09T04:21:31Z Management of non-alcoholic fatty liver disease in patients with sarcopenia Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:31Z Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan Huang C.-F.; Kuo H.-T.; Chang T.-S.; Lo C.-C.; Hung C.-H.; Huang C.-W.; Chong L.-W.; Cheng P.-N.; Yeh M.-L.; Peng C.-Y.; Cheng C.-Y.; Huang J.-F.; Bair M.-J.; Lin C.-L.; Yang C.-C.; Wang S.-J.; Hsieh T.-Y.; Lee T.-H.; Lee P.-L.; Wu W.-C.; Su W.-W.; Yang S.-S.; Wang C.-C.; Hu J.-T.; Mo L.-R.; Chen C.-T.; Huang Y.-H.; Chang C.-C.; Huang C.-S.; Chen G.-Y.; Kao C.-N.; Tai C.-M.; Liu C.-J.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; JIA-HORNG KAO; Lin H.-C.; Chuang W.-L.; Chen C.-Y.; Tseng K.-C.; Yu M.-L.
臺大學術典藏 2022-09-09T04:21:32Z Highlights JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:32Z Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients (Hepatology International, (2021), 15, 3, (582-592), 10.1007/s12072-021-10186-7) Cheng H.-R.; Yang H.-C.; Lin S.-R.; Yang T.-Y.; Lin Y.-Y.; Su T.-H.; Tseng T.-C.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:33Z Highlights JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:33Z Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan Hong C.-M.; Lin Y.-Y.; Liu C.-J.; Lai Y.-Y.; Yeh S.-H.; Yang H.-C.; JIA-HORNG KAO; Hsu S.-J.; Huang Y.-H.; Yang S.-S.; Kuo H.-T.; Cheng P.-N.; Yu M.-L.; Chen P.-J.
臺大學術典藏 2022-09-09T04:21:34Z Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis Liu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; Fang Y.-J.; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:34Z Last Mile to Microelimination of Hepatitis C Virus Infection Among People Living With Human Immunodeficiency Virus Liu C.-H.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:34Z Highlights JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:35Z Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort) Hsu W.-F.; Tsai P.-C.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y.
臺大學術典藏 2022-09-09T04:21:35Z Investigating the prevalence and clinical effects of hepatitis delta viral infection in Taiwan Lee W.-C.; Chen T.-K.; Han H.-F.; Lin Y.-C.; Hwang Y.-M.; JIA-HORNG KAO; Chen P.-J.; Liu C.-J.
臺大學術典藏 2022-09-09T04:21:36Z Highlights JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:36Z Highlights JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:36Z Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan Hsieh M.-H.; Bair M.-J.; Tsai P.-C.; Tseng K.-C.; Lo C.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Yu M.-L.; Chuang W.-L.; T-COACH investigators
臺大學術典藏 2022-09-09T04:21:37Z Three heads are better than two: Hepatitis b core-related antigen as a new predictor of hepatitis b virus-related hepatocellular carcinoma Wu J.-W.; JIA-HORNG KAO; Tseng T.-C.
臺大學術典藏 2022-09-09T04:21:37Z Highlights JIA-HORNG KAO

Showing items 2290511-2290535 of 2346269  (93851 Page(s) Totally)
<< < 91616 91617 91618 91619 91620 91621 91622 91623 91624 91625 > >>
View [10|25|50] records per page